Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -46.30% is 88% below its 5-year average of -24.57%, near the low end of its 5-year range (-51.50%–-5.83%).
48.23% below its 12-month average of -31.23%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -0.65%.
RETURN ON ASSETS (ROA)
-46.30%
RETURN ON ASSETS (ROA) AVG TTM
-31.23%
RETURN ON ASSETS (ROA) AVG 3Y
-20.32%
RETURN ON ASSETS (ROA) AVG 5Y
-24.57%
RETURN ON ASSETS (ROA) AVG 10Y
-26.63%
RETURN ON ASSETS (ROA) AVG 15Y
-46.65%
RETURN ON ASSETS (ROA) AVG 20Y
-69.71%
CURRENT VS TTM AVG
-48.23%
CURRENT VS 3Y AVG
-127.80%
CURRENT VS 5Y AVG
-88.47%
CURRENT VS 10Y AVG
-73.84%
CURRENT VS 15Y AVG
+0.76%
CURRENT VS 20Y AVG
+33.58%
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-43.61%
vs the sector median at left
Sanara MedTech Inc.
Market Cap
$321.62M
Return on Assets (ROA)
-46.30%
TTM Avg
-31.23%
3Y Avg
-20.32%
5Y Avg
-24.57%
Market Cap
$322.03M
Return on Assets (ROA)
-70.63%
TTM Avg
-82.15%
3Y Avg
-59.06%
5Y Avg
-50.33%
Market Cap
$323.14M
Return on Assets (ROA)
-39.85%
TTM Avg
-37.20%
3Y Avg
-38.95%
5Y Avg
-33.46%
Market Cap
$320.23M
Return on Assets (ROA)
53.28%
TTM Avg
-50.19%
3Y Avg
-57.97%
5Y Avg
-53.56%
Market Cap
$320.22M
Return on Assets (ROA)
-90.17%
TTM Avg
-81.88%
3Y Avg
-55.65%
5Y Avg
-44.24%
Market Cap
$325.26M
Return on Assets (ROA)
-160.64%
TTM Avg
-128.90%
3Y Avg
-103.44%
5Y Avg
-103.44%
Market Cap
$312.35M
Return on Assets (ROA)
-28.22%
TTM Avg
-29.68%
3Y Avg
-31.08%
5Y Avg
-26.24%
Market Cap
$302.45M
Return on Assets (ROA)
-24.94%
TTM Avg
-31.51%
3Y Avg
-135.72%
5Y Avg
-152.11%
Market Cap
$303.90M
Return on Assets (ROA)
-96.57%
TTM Avg
-96.57%
3Y Avg
-96.57%
5Y Avg
-96.57%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sanara MedTech Inc. (SMTI) | $321.62M | -46.30% | -31.23% | -20.32% | -24.57% |
| Cabaletta Bio, Inc. (CABA)vs › | $322.03M | -70.63% | -82.15% | -59.06% | -50.33% |
| ClearPoint Neuro, Inc. (CLPT)vs › | $323.14M | -39.85% | -37.20% | -38.95% | -33.46% |
| Agenus Inc. (AGEN)vs › | $320.23M | 53.28% | -50.19% | -57.97% | -53.56% |
| Avita Medical Inc. (RCEL)vs › | $320.22M | -90.17% | -81.88% | -55.65% | -44.24% |
| CapsoVision, Inc. (CV)vs › | $325.26M | -160.64% | -128.90% | -103.44% | -103.44% |
| C4 Therapeutics, Inc. (CCCC)vs › | $312.35M | -28.22% | -29.68% | -31.08% | -26.24% |
| Benitec Biopharma Inc. (BNTC)vs › | $302.45M | -24.94% | -31.51% | -135.72% | -152.11% |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $303.90M | -96.57% | -96.57% | -96.57% | -96.57% |
| Relmada Therapeutics, Inc. (RLMD)vs › | $348.23M | -28.27% | -117.81% | -109.90% | -91.03% |
ROA
-46.3%
ROE
-403.0%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -51.50% |
| 2024-12-31 | -10.97% |
| 2023-12-31 | -5.83% |
| 2022-12-31 | -13.00% |
| 2021-12-31 | -21.77% |
| 2020-12-31 | -44.33% |
| 2019-12-31 | -25.31% |
| 2018-12-31 | -19.74% |
| 2017-12-31 | 14.94% |
| 2016-12-31 | -19.15% |
| 2015-12-31 | -96.31% |
| 2014-12-31 | -152.05% |
| 2013-12-31 | -424.51% |
| 2012-12-31 | -132.41% |
| 2011-12-31 | -332.44% |
| 2010-12-31 | -75.71% |
| 2009-12-31 | -48.24% |
| 2008-12-31 | -1168.78% |
| 2007-12-31 | -133.77% |
| 2006-12-31 | -125.64% |
| 2005-12-31 | -293.97% |
| 2004-12-31 | -3094.66% |
| 2001-12-31 | -104.52% |
| 2000-12-31 | -96.94% |
| 1999-12-31 | 32.94% |
